Indication · GI, Urology & Nephrology
Liver disease and liver cancer
Last checked: Nov 20, 2026Source: FDA, ClinicalTrials.gov
Devices
196
Cleared or approved since 2000
PMA and De Novo
28
Higher-risk or first-of-kind devices
Breakthrough devices
4
Authorized through June 30, 2026
Recruiting device trials
82
693 device trials in all
Breakthrough-designated devices
- LIAISON® XL MUREX Anti-HDV (318260)DiaSorin, Inc. · 2025
3 more devices with a free account
Devices
20 devices via PMA. PMA and De Novo devices first, then devices with the most FDA decisions. Each opens a full summary.
- OrganOx metra® System
Organox Limited · PMA · Normothermic Machine Perfusion System For The Preservation Of Donor Livers Prior To Transplantation · newest 2026 · 16 decisions
19 more devices with a free account
Device trials
Device studies on ClinicalTrials.gov for this condition, any status, newest update first.
- Proximal Splenic Artery Embolization (PSAE) for the Treatment of Refractory Ascites in Decompensated CirrhosisNot yet recruiting
Massachusetts General HospitalAcademic, hospital or other
NCT07755059 · 60 participants (planned) · Start Dec 2026 · Primary completion Apr 1, 2030
Device: Proximal Splenic Artery Embolization · For: Ascites; Liver Cirrhosis; Hypertension, Portal
Sites: Boston, Massachusetts · 3 sites in all
692 more trials with a free account
Device types
FDA product codes mapped to this indication. The mapping was made with AI help and may include a few loose fits.
- Diazo Colorimetry, Bilirubin (CIG)38
- Hepatitis A Test (Antibody And Igm Antibody) (LOL)24
- Nitrophenylphosphate, Alkaline Phosphatase Or Isoenzymes (CJE)22
- Peritoneal, Drainage Catheter For Refractory Ascites, Long-Term Indwelling (PNG)11
- Nadh Oxidation/Nad Reduction, Ast/Sgot (CIT)10
- Enzymatic Method, Ammonia (JIF)9
- Antimitochondrial Antibody, Indirect Immunofluorescent, Antigen, Control (DBM)8
- Enzymatic Method, Bilirubin (JFM)8
- Radiological Image Processing Software For Ablation Therapy Planning And Evaluation (QTZ)7
- Shunt, Peritoneal (KPM)6
- Shunt, Portosystemic, Endoprosthesis (MIR)6
- Nadh Oxidation/Nad Reduction, Alt/Sgpt (CKA)4
- Tracking, Soft Tissue, Intraoperative (OEW)4
- Microspheres Radionuclide (NAW)3
- Autoantibodies, Lkm-1 (Liver/Kidney Microsome, Type 1) (NBS)3
- Autoantibodies, Anti-Soluble Liver Antigen (Sla), Autoimmune Hepatitis (NIY)3
- Liver Iron Concentration Imaging Companion Diagnostic For Deferasirox (PCS)3
- Apparatus, Hemoperfusion, Sorbent (FLD)2
- Radioimmunoassay, Cholyglycine, Bile Acids (KWW)2
- Autoantibodies, Nuclear Pore Glycoprotein Gp210 (NRI)2
- Test, Alpha Fetoprotein L3 Subfraction (Afp-L3%), For Hepatocellular Carcinoma Risk Assessment (NSF)2
- Normothermic Machine Perfusion System For The Preservation Of Donor Livers Prior To Transplantation (QQK)2
- Post-Ablation Tissue Response Prediction Software (QZL)2
- Hydrazone Colorimetry, Ast/Sgot (CIS)1
- Indirect Copper Assay, Ceruloplasmin (JFR)1
- Photometric Method, Ammonia (JID)1
- Colorimetric Method, Gamma-Glutamyl Transpeptidase (JPZ)1
- Radioimmunoassay, Conjugated Sulfalithocholic (Slcg) Acid, Bile Acids (KWX)1
- Antibodies, Anti-Actin, Anti-Smooth Muscle (NJF)1
- Autoantibodies, Nuclear Body Protein, Sp100 (NUM)1
Research
- Device studies on liver cirrhosis across PubMed, Europe PMC and OpenAlex
- PubMed ↗
- Google Scholar ↗
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.